California’s economic growth slowing
California’s economic growth has slowed compared to the U.S. economy and the trend of slowing growth will continue over the next two years with GDP growth declining to 2.3 percent, the California Lutheran University Center for Economic Research and Forecasting said in its Sept. 21 forecast. Job growth is expected to drop to 1.3 percent, Read More →
Read More →
PGA Tour Champions give Sherwood course high marks
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Frontier relocating to new facility in Thousand Oaks
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Dubroff: CLU’s Hub 101 bridging tech startup divide in Ventura County
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →FDA approves Amgen cancer treatment biosimilar Mvasi
The U.S. Food and Drug Administration approved a cancer treatment biosimilar developed in partnership between Allergan and Thousand Oaks-based Amgen, the company announced Sept. 13. Mvasi was approved to treat five types of cancer in combination with other therapies. “The approval of Mvasi marks a significant milestone for healthcare practitioners and patients as the first Read More →
Read More →Study finds Amgen asthma drug is effective
An asthma drug being developed by Thousand Oaks-based Amgen and AstraZeneca showed significant yearly reduction for patients, according to a study published in the New England Journal of Medicine Sept. 6. Patients with severe, uncontrolled asthma using tezepelumab saw a drop in annual exacerbation compared with patients taking a placebo, Amgen said in a news Read More →
Read More →Our view: Sexual abuse bill would protect entrepreneurs from investors
Sen. Hannah-Beth Jackson (D-Santa Barbara) has been getting well-deserved national attention for a timely effort to address sexual abuse in the venture capital industry. She has introduced a draft of SB 224, a bill that aims to deter investors from making unwanted sexual advances to entrepreneurs seeking funding. Her effort comes at a time when Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
